A symposium focused on immune engineering and modulation.
Immune Modulation & Engineering Symposium
This event brings together experts in science and medicine to share new ideas and work together on better ways to treat cancer and other diseases by improving how our immune system works, while also helping young scientists learn about this exciting field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drexel University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10992678 on NIH RePORTER |
What this research studies
This symposium aims to gather experts in biomedical engineering and immunology to discuss advancements in immune engineering. Attendees will share innovative ideas and collaborate on solutions for treating cancer, infectious diseases, and immunological disorders. The event will also introduce young scientists to the field and explore challenges and opportunities in developing new technologies. By fostering interdisciplinary collaboration, the symposium seeks to enhance the understanding and application of immune modulation.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include children and young individuals (0-21 years old) with cancer or immunological disorders.
Not a fit: Patients with conditions unrelated to immune modulation or those outside the age range of 0-21 may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments and technologies that improve patient outcomes in cancer and other immune-related conditions.
How similar studies have performed: Previous research in immune engineering has shown promise in developing innovative treatments, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- Drexel University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Spiller, Kara Lorraine — Drexel University
- Study coordinator: Spiller, Kara Lorraine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.